Therapy For Dementia Patients
-
{
- All
- News
-
What I Tell Families When They Ask: Should We Put My Parent On The New Drug, Lormalzi?
Lormalzi is not a cure. I say this not to take away hope, but because understanding this is what allows families to make decisions rooted in reality rather than desperation.
-
Who Should Take Lormalzi? Alzheimer's Expert Explains Benefits And Risks
Neurologists say Lormalzi (donanemab), India's newly launched Alzheimer's therapy, may help slow cognitive decline in carefully selected patients with early disease. Experts explain who may benefit, who should avoid it, and the risks involved.
-
Eli Lilly Launches Alzheimer's Drug Lormalzi Priced At Rs 91,688 Per Vial In India
Eli Lilly has launched Lormalzi (donanemab) in India for early Alzheimer's disease at Rs91,688 per vial. The once-monthly therapy targets amyloid plaques and may help slow cognitive decline in eligible patients with mild symptoms.
-
Ozempic Might Preserve Lean Body Mass Better Than Mounjaro: Study
Both tirzepatide and semaglutide belong to a class of drugs that mimic hormones involved in appetite regulation. Semaglutide works by mimicking GLP-1, a hormone that helps control hunger and blood sugar levels.
-
Other Kinds Of Dementias You May Not Know About
Understanding these other forms of dementia is essential for early detection, proper treatment, and support for both patients and caregivers.
-
Mental Health: 6 Reasons Why You Should Consider Getting Therapy
Read on as we share some ways in which therapy can be helpful.
-
Mental Health: Here's How Therapy Is An Essential Aspect Of A Healthy Lifestyle
Therapy: In this article, we discuss the many benefits of adding therapy to your lifestyle for a healthy life.
-
Dementia: Could Therapy Be Beneficial For Dementia Patients?
Dementia: Patients with moderate cognitive impairment or early-stage dementia benefit most from physical and cognitive therapy.
-
Alternatives for treating dementia
Music, pets and aromatherapy could be used to calm agitated or delusional patients before using drugs.
-
What I Tell Families When They Ask: Should We Put My Parent On The New Drug, Lormalzi?
Lormalzi is not a cure. I say this not to take away hope, but because understanding this is what allows families to make decisions rooted in reality rather than desperation.
-
Who Should Take Lormalzi? Alzheimer's Expert Explains Benefits And Risks
Neurologists say Lormalzi (donanemab), India's newly launched Alzheimer's therapy, may help slow cognitive decline in carefully selected patients with early disease. Experts explain who may benefit, who should avoid it, and the risks involved.
-
Eli Lilly Launches Alzheimer's Drug Lormalzi Priced At Rs 91,688 Per Vial In India
Eli Lilly has launched Lormalzi (donanemab) in India for early Alzheimer's disease at Rs91,688 per vial. The once-monthly therapy targets amyloid plaques and may help slow cognitive decline in eligible patients with mild symptoms.
-
Ozempic Might Preserve Lean Body Mass Better Than Mounjaro: Study
Both tirzepatide and semaglutide belong to a class of drugs that mimic hormones involved in appetite regulation. Semaglutide works by mimicking GLP-1, a hormone that helps control hunger and blood sugar levels.
-
Other Kinds Of Dementias You May Not Know About
Understanding these other forms of dementia is essential for early detection, proper treatment, and support for both patients and caregivers.
-
Mental Health: 6 Reasons Why You Should Consider Getting Therapy
Read on as we share some ways in which therapy can be helpful.
-
Mental Health: Here's How Therapy Is An Essential Aspect Of A Healthy Lifestyle
Therapy: In this article, we discuss the many benefits of adding therapy to your lifestyle for a healthy life.
-
Dementia: Could Therapy Be Beneficial For Dementia Patients?
Dementia: Patients with moderate cognitive impairment or early-stage dementia benefit most from physical and cognitive therapy.
-
Alternatives for treating dementia
Music, pets and aromatherapy could be used to calm agitated or delusional patients before using drugs.
